The Beauty Health Company

NASDAQ:SKIN

2.05 (USD) • At close September 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Revenue 78.18769.5883.49578.80290.59481.40396.897.4117.586.27898.13388.792103.53675.41577.88968.14766.50847.54237.8834.5614.11632.53649.922
Cost of Revenue 29.0752131.14938.15349.65433.04251.111049.632.17432.95927.42931.88223.47821.12822.07219.25715.80214.84313.6039.8413.60718.966
Gross Profit 49.11248.5852.34640.64940.9448.36145.7-12.667.954.10465.17461.36371.65451.93756.76146.07547.25131.7423.03720.9574.27618.92930.956
Gross Profit Ratio 0.6280.6980.6270.5160.4520.5940.472-0.1290.5780.6270.6640.6910.6920.6890.7290.6760.710.6680.6080.6060.3030.5820.62
Reseach & Development Expenses 1.2510.9981.2221.1081.1592.80731.82.92.3361.4462.1672.6012.231.8751.882.9881.4520.860.5770.5971.3761.252
General & Administrative Expenses 27.45233.56531.75633.43631.4128.86128.9753735.130.37928.47223.78227.58526.26125.04519.244.40210.81110.997.0545.4127.1926.513
Selling & Marketing Expenses 23.10926.0426.52527.6230.48233.68432.02530.74338.69939.02139.76744.88136.40737.05330.45126.21417.09515.89810.5416.18617.69716.807
SG&A 50.56159.60558.28161.05661.89262.5456167.778.169.07867.49363.54972.46662.66862.09849.65170.61627.90626.88817.59511.59824.88923.32
Other Expenses 000000000.04700-0.36100-0.1600-0.007-0.1310.0230.0560.0050
Operating Expenses 51.81260.60359.50362.16463.05165.3526469.58171.41468.93965.71675.06764.89863.97351.53173.60429.35827.74818.17212.19526.26523.879
Operating Income -2.7-12.023-7.157-21.515-22.111-16.991-18.3-82.1-13.1-17.31-5.154-4.353-1.755-12.961-7.212-5.456-26.3532.382-4.7112.785-7.919-7.3366.384
Operating Income Ratio -0.035-0.173-0.086-0.273-0.244-0.209-0.189-0.843-0.111-0.201-0.053-0.049-0.017-0.172-0.093-0.08-0.3960.05-0.1240.081-0.561-0.2250.128
Total Other Income Expenses Net 21.4192.819-4.5615.17221.9615.6539.5611.76214.317-6.6116.3583.4519.76248.083-9.036-210.818-114.895-5.962-5.83-5.592-5.53-4.348-3.664
Income Before Tax 18.719-9.204-11.718-16.343-0.151-1.338-8.8-70.31.2-23.9212.593-0.9028.00735.122-16.248-216.274-141.248-3.58-10.541-2.807-13.449-11.6842.72
Income Before Tax Ratio 0.239-0.132-0.14-0.207-0.002-0.016-0.091-0.7220.01-0.2770.026-0.010.0770.466-0.209-3.174-2.124-0.075-0.278-0.081-0.953-0.3590.054
Income Tax Expense -0.9930.892-1.3881.948-0.353-0.6590.63.479-2.2-3.662-1.222-0.8210.0762.6151.063-1.129-1.87-0.306-3.048-0.593-3.052-2.6140.013
Net Income 19.712-10.096-10.33-18.2910.202-0.679-9.4-73.83.364-20.2593.815-0.0816.31731.455-17.311-215.145-139.378-3.274-7.493-2.214-10.397-9.072.545
Net Income Ratio 0.252-0.145-0.124-0.2320.002-0.008-0.097-0.7580.029-0.2350.039-0.0010.0610.417-0.222-3.157-2.096-0.069-0.198-0.064-0.737-0.2790.051
EPS 0.16-0.081-0.083-0.15-0.12-0.01-0.073-0.560.025-0.150.028-0.0010.0420.21-0.12-1.63-1.52-0.026-0.06-0.018-0.083-0.07251.72
EPS Diluted 0.03-0.081-0.083-0.15-0.1-0.095-0.073-0.560.025-0.150.028-0.0010.0420.21-0.12-1.63-1.52-0.026-0.06-0.018-0.083-0.07251.72
EBITDA 28.264-0.542-2.696-4.31911.21810.339-8.387-59.55214.501-14.248-4.6513.84918.09644.167-6.777-211.213-131.8495.73-1.1876.492-4.013-3.99910.057
EBITDA Ratio 0.361-0.008-0.032-0.0550.1240.127-0.087-0.6110.123-0.165-0.0470.0430.1750.586-0.087-3.099-1.9820.121-0.0310.188-0.284-0.1230.201